Page last updated: 2024-10-19

niacin and Exanthem

niacin has been researched along with Exanthem in 13 studies

Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Pellagra is caused by niacin (vitamin B3) deficiency and patients with pellagra present with a characteristic rash."8.12Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study. ( Auld, AF; Buono, N; Chilikutali, L; Chisuwo, L; Chiwaula, MJ; da Silva, R; Girma, B; Gunde, LJ; Gutreuter, S; Jahn, A; Kalua, T; Kaunda, E; Kim, EJ; Kumwenda, T; Maida, A; Maphosa, T; Marshall, RE; Mbewe, K; Mekonnen, TF; Melgar, M; Mhango, V; Moffitt, A; Mponda, K; Mtoto, F; Muula, AS; Mwamale, S; Mwenyeheri, G; Nabity, SA; Nagoli, E; Ngongonda, D; Nyirenda, R; Odo, M; Oeltmann, JE; Sharma, AJ; Sunguti, J; Surie, D; Williams, AM; Woelk, G; Zimba, SB, 2022)
"The relationship of the exanthematous eruption with lower body weight and the increase in dosage suggests a pharmacokinetic effect that may be related to increased exposure to niacin or its metabolites and provoked by inhibition of the DP1 receptor with laropiprant, as we have not seen this rash with niacin used alone."7.79A high incidence of exanthematous eruption associated with niacin/laropiprant combination in Hong Kong Chinese patients. ( Chang, M; Hu, M; Tomlinson, B; Yang, YL, 2013)
"Pellagra is caused by niacin (vitamin B3) deficiency and patients with pellagra present with a characteristic rash."4.12Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study. ( Auld, AF; Buono, N; Chilikutali, L; Chisuwo, L; Chiwaula, MJ; da Silva, R; Girma, B; Gunde, LJ; Gutreuter, S; Jahn, A; Kalua, T; Kaunda, E; Kim, EJ; Kumwenda, T; Maida, A; Maphosa, T; Marshall, RE; Mbewe, K; Mekonnen, TF; Melgar, M; Mhango, V; Moffitt, A; Mponda, K; Mtoto, F; Muula, AS; Mwamale, S; Mwenyeheri, G; Nabity, SA; Nagoli, E; Ngongonda, D; Nyirenda, R; Odo, M; Oeltmann, JE; Sharma, AJ; Sunguti, J; Surie, D; Williams, AM; Woelk, G; Zimba, SB, 2022)
" Based on the characteristics of the dermatitis and on a rapid response to niacin replacement, the diagnosis of pellagra was carried out."3.80Pellagra in a patient with primary Sjögren's syndrome. ( Ben Ghorbel, I; Chelly, I; Houman, H; Litaiem, N, 2014)
"The relationship of the exanthematous eruption with lower body weight and the increase in dosage suggests a pharmacokinetic effect that may be related to increased exposure to niacin or its metabolites and provoked by inhibition of the DP1 receptor with laropiprant, as we have not seen this rash with niacin used alone."3.79A high incidence of exanthematous eruption associated with niacin/laropiprant combination in Hong Kong Chinese patients. ( Chang, M; Hu, M; Tomlinson, B; Yang, YL, 2013)
"Niacin has beneficial effects on plasma lipoproteins and has demonstrated clinical benefits in reducing cardiovascular events and atherosclerosis progression."2.44Safety considerations with niacin therapy. ( Bays, HE; Guyton, JR, 2007)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19903 (23.08)18.7374
1990's1 (7.69)18.2507
2000's1 (7.69)29.6817
2010's4 (30.77)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Nabity, SA1
Mponda, K1
Gutreuter, S1
Surie, D1
Zimba, SB1
Chisuwo, L1
Moffitt, A1
Williams, AM1
Sharma, AJ1
Marshall, RE1
Chiwaula, MJ1
da Silva, R1
Kumwenda, T1
Chilikutali, L1
Mwamale, S1
Nagoli, E1
Mwenyeheri, G1
Ngongonda, D1
Kaunda, E1
Mtoto, F1
Mhango, V1
Mbewe, K1
Melgar, M1
Odo, M1
Jahn, A1
Buono, N1
Maida, A1
Girma, B1
Kalua, T1
Nyirenda, R1
Sunguti, J1
Woelk, G1
Gunde, LJ1
Mekonnen, TF1
Maphosa, T1
Kim, EJ1
Auld, AF1
Muula, AS1
Oeltmann, JE1
Yano, H1
Kinjo, M1
Yang, YL1
Hu, M1
Chang, M1
Tomlinson, B1
THIERS, H1
RACOUCHOT, J1
FERRIERA-MARQUES, J1
van UDEN, N1
Guyton, JR1
Bays, HE1
Morse, JW1
Morse, SJ1
Patterson, J1
Alagesan, M1
Chidambaram, Y1
Tew, JC1
Harrington, L1
Elsayed, H1
Mlawa, G1
Dalla, A1
Kumar, S1
De, D1
Ben Ghorbel, I1
Litaiem, N1
Chelly, I1
Houman, H1
Kesty, K1
De Luca, JF1
Taylor, SL1
Sangueza, OP1
BOITTELLE, G1
BOITTELLE-LENTULO, C1
SERRIER, J1
HOURCARD, J1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Niacin Supplementation on Systemic Nicotinamide Adenine Dinucleotide (NAD+) Metabolism, Physiology and Muscle Performance in Healthy Controls and Mitochondrial Myopathy Patients[NCT03973203]15 participants (Actual)Interventional2014-06-01Completed
NiaMIT (NiaMIT_0001) Continuation for Early-stage Mitochondrial Myopathy Patients to Investigate the Effect of Niacin Supplementation on Systemic Nicotinamide Adenine Dinucleotide (NAD+) Metabolism, Physiology and Muscle Performance[NCT04538521]3 participants (Actual)Interventional2019-02-11Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for niacin and Exanthem

ArticleYear
Safety considerations with niacin therapy.
    The American journal of cardiology, 2007, Mar-19, Volume: 99, Issue:6A

    Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Chemistry, Pharmaceutical; Clinical

2007
Safety considerations with niacin therapy.
    The American journal of cardiology, 2007, Mar-19, Volume: 99, Issue:6A

    Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Chemistry, Pharmaceutical; Clinical

2007
Safety considerations with niacin therapy.
    The American journal of cardiology, 2007, Mar-19, Volume: 99, Issue:6A

    Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Chemistry, Pharmaceutical; Clinical

2007
Safety considerations with niacin therapy.
    The American journal of cardiology, 2007, Mar-19, Volume: 99, Issue:6A

    Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Chemistry, Pharmaceutical; Clinical

2007

Other Studies

12 other studies available for niacin and Exanthem

ArticleYear
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study.
    The Lancet. Global health, 2022, Volume: 10, Issue:5

    Topics: Antitubercular Agents; Case-Control Studies; Exanthema; Female; HIV Infections; Humans; Isoniazid; M

2022
Pruritic Rash and Diarrhea.
    JAMA, 2021, Mar-16, Volume: 325, Issue:11

    Topics: Aged, 80 and over; Diarrhea; Exanthema; Fatal Outcome; Female; Humans; Niacin; Pellagra; Pruritus; S

2021
A high incidence of exanthematous eruption associated with niacin/laropiprant combination in Hong Kong Chinese patients.
    Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:6

    Topics: Adult; Aged; Anti-Inflammatory Agents; Biopsy; Body Weight; Drug Combinations; Drug Eruptions; Exant

2013
[Eruptions following therapeutic use of nicotinic acid for vasodilation].
    Lyon medical, 1952, Jul-06, Volume: 187, Issue:27

    Topics: Autonomic Nervous System Diseases; Exanthema; Humans; Niacin; Nicotinic Acids; Vasodilation

1952
[Combined penicillin-nicotinic acid therapy of lichen ruber verrucosus].
    Archiv fur Dermatologie und Syphilis, 1950, Volume: 191

    Topics: Exanthema; Humans; Lichen Planus; Lichens; Niacin; Nicotinic Acids; Penicillins; Psychotherapy, Mult

1950
Niacin reaction: common vitamin, uncommon ED diagnosis.
    The American journal of emergency medicine, 1999, Volume: 17, Issue:3

    Topics: Adult; Diagnosis, Differential; Edible Grain; Exanthema; Humans; Hypersensitivity, Immediate; Male;

1999
Pellagra.
    The New England journal of medicine, 2022, Mar-10, Volume: 386, Issue:10

    Topics: Diarrhea; Exanthema; Female; Humans; Middle Aged; Neck; Pellagra; Skin

2022
Pellagra as a differential diagnosis in the confused patient on the acute medical unit.
    BMJ case reports, 2022, Nov-02, Volume: 15, Issue:11

    Topics: Alcoholism; Confusion; Diagnosis, Differential; Diarrhea; Exanthema; Humans; Male; Pellagra; Substan

2022
Elderly patient of Crohn's disease with dementia and edematous red plaques on dorsum of hands.
    European journal of internal medicine, 2019, Volume: 68

    Topics: Aged; Crohn Disease; Dementia; Diarrhea; Exanthema; Hand; Humans; Male; Pellagra

2019
Pellagra in a patient with primary Sjögren's syndrome.
    BMJ case reports, 2014, Jun-18, Volume: 2014

    Topics: Adult; Exanthema; Facial Dermatoses; Female; Hand Dermatoses; Humans; Pellagra; Sjogren's Syndrome;

2014
Scaly Erythematous Acral Eruption: Question. Scaly erythematous acral eruption.
    The American Journal of dermatopathology, 2016, Volume: 38, Issue:1

    Topics: Adult; Erythema; Exanthema; Female; Hand Dermatoses; Humans; Pellagra

2016
[Pellagroid eruption associated with mental disorders in an alcoholic].
    Annales medico-psychologiques, 1950, Volume: 108, Issue:2 2

    Topics: Alcoholism; Exanthema; Humans; Mental Disorders; Pellagra

1950
chemdatabank.com